To determine how IL-2/JES6 increases IgE-mediated mast cell responses and exacerbates anaphylaxis, we investigated the effects of IL-2/JES6 treatment on the size of mast cell populations in the gut, early events in mast cell activation, and cytokine responses by T helper cells. The gene discussed is IGHE; the disease is anaphylaxis.